CIRESI, Alessandro
CIRESI, Alessandro
Biomedico di Medicina Interna e Specialistica (attivo dal 01/01/2013 al 31/12/2018)
Adrenal incidentaloma: a new contributing factor in metabolic syndrome
2004-01-01 M BONO; M AMATO; A CIRESI; S MERLINO; G D'ACQUISTO; GIORDANO C; GALLUZZO A
Adrenal incidentaloma: a new contributing factor in metabolic syndrome?
2004-01-01 Bono, M; Amato, M; Ciresi, A; Merlino, S; D’Acquisto, G; Giordano, C
Adrenal morphology and function in acromegalic patients in relation to disease activity.
2009-01-01 Ciresi, A; Amato, MC; Vetro, C; Lo Coco, R; Galluzzo, A; Giordano, C
Alta prevalenza di Sindrome dell’ovaio policistico in donne diabetiche di tipo 1 in età fertile.
2012-01-01 Guarnotta, V; Amato, MC; Radellini, S; Ciresi, A; Giordano, C
Alte dosi di cabergolina migliorano i parametri metabolici in pazienti affetti da prolattinoma.
2013-01-01 Ciresi, A; Amato, MC; Guarnotta, V; Lo Castro, F; Giordano, C
Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index
2015-01-01 Di Somma, C.; Ciresi, A.; Amato, M.; Savastano, S.; Savanelli, M.; Scarano, E.; Colao, A.; Giordano, C.
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni contro regolatori.
2010-01-01 Ciresi, A; Amato, MC; Galluzzo, A; Giordano C
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni controregolatori: ruolo del GH
2010-01-01 Ciresi, A.; Amato, M.; Galluzzo, A.; Giordano, C.
Buon compenso glicemico nei pazienti acromegalici affetti da diabete secondario.
2010-01-01 Mastinu, M; Cambuli, VM; Pigliaru, F; Auriemma, RS; Pivonello, R; Ciresi, A; Amato, MC; Mariotti, S; Giordano, C; Colao, AM; Baroni, MG
Changes in lipid profile and adipokine levels in GH deficient children during GH replacement therapy.
2006-01-01 Ciresi A; Amato MC; Criscimanna A; Mattina A; Malato M; Smeraldi L; Galluzzo A; Giordano C
Circulating adipokine levels in diabetic patients with Cushing disease on pasireotide treatment compared with patients with type 2 diabetes mellitus
2017-01-01 Guarnotta, V.; Pizzolanti, G.; Ciresi, A.; Giordano, C.
Circulating Irisin Levels in Children with GH Deficiency before and after 1 Year of GH Treatment
2019-01-01 Ciresi, Alessandro*; Pizzolanti, Giuseppe; Guarnotta, Valentina; Giordano, Carla
Clamp euglicemico iperinsulinemico e test al glucagone come utili strumenti di valutazione degli effetti metabolici della terapia sostitutiva con GH.
2014-01-01 Ciresi, A; Amato, MC; Cicciò, F; Giordano, C
Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study
2012-01-01 Giordano, C.; Ciresi, A.; Amato, M.; Pivonello, R.; Auriemma, R.; Grasso, L.; Galluzzo, A.; Colao, A.
Clinical and metabolic impact of three-times-weekly versus daily growth hormone (GH) treatment in naïve GH-deficient children
2017-01-01 Ciresi, A; Cicciò, F; Radellini, S; Calcaterra, AM; Guarnotta, V; Giordano, C
Commento a "Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children "
2016-01-01 Ciresi, A.; Giordano, C.
Commento a "The impact of real practice inappropriateness and devices' inefficiency to variability in growth hormone consumption"
2015-01-01 Ciresi, A.; Giordano, C.
Comparison between euglycemic hyperinsulinemic clamp and surrogate indices of insulin sensitivity in children with growth hormone deficiency
2018-01-01 Ciresi, Alessandro; Guarnotta, Valentina; Pizzolanti, Giuseppe; Giordano, Carla*
Comparison of clinical and metabolic effects of pasireotide and pituitary surgery in Cushing disease
2017-01-01 Guarnotta, V.; Ciresi, A.; Pizzolanti, G.; Giordano, C.
Complete biochemical control and pituitary adenoma disappearance in a child with gigantism: efficacy of octreotide therapy
2011-01-01 Ciresi, A.; Amato, M.; Galluzzo, A.; Giordano, C.